Faculty Disclosures
| Bhupendra O. Khatri, MD, FAAN |
Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen. |
| Morris Levin, MD, FAAN |
Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care. |
| George W. Petty, MD |
No disclosure on file
|
| Robert D. Brown, Jr., MD, MPH, FAAN |
Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care. |
| Panayiotis Mitsias, MD |
Dr. Mitsias has nothing to disclose. |
| Wade S. Smith, MD, PhD |
Dr. Smith has stock in MindRhythm, Inc. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care. |
| Gottfried Schlaug, MD |
No disclosure on file
|
| Marwan N. Sabbagh, MD, FAAN |
Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF. |
| Hamza I. Maqsood, MD |
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Scott E. Kasner, MD, FAAN |
Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Diamedica. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from Bristol-Myers Squibb. The institution of Dr. Kasner has received research support from Medtronic. The institution of Dr. Kasner has received research support from WL Gore. |
| Hideki Garren, MD, PhD |
Dr. Garren has received personal compensation for serving as an employee of Prothena. Dr. Garren has received personal compensation for serving as an employee of Genentech. Dr. Garren has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Coya. |
| David Kreitzman, MD |
Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kreitzman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cereval. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Pharmaceutical. Dr. Kreitzman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Kreitzman has received research support from pharma 2b. Dr. Kreitzman has received research support from Neurocrine. Dr. Kreitzman has received research support from Addex. Dr. Kreitzman has received research support from Amneal. |
| Dawn O. Kleindorfer, MD, FAAN |
Dr. Kleindorfer has nothing to disclose. |
| Alejandro A. Rabinstein, MD, FAAN |
Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. |
| Nerses Sanossian, MD, FAAN |
Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma. |
| Mona Sazgar, MD |
Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care. |
| Steven R. Messe, MD, FAHA, FAAN |
Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group. |
| Jack J. Lin, MD |
Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea. |
| Nazli A. Janjua, MD, MBBS |
Dr. Janjua has nothing to disclose. |
| Peter S. Chin, MD |
No disclosure on file
|
| Karen C. Albright, DO, DO, PhD, MS, MPH |
Dr. Albright has nothing to disclose. |
| Andrew Russman, DO, FAAN |
Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Tony Alvaro, MBBS, FRACP |
No disclosure on file
|
| Muhammad F. Suri, MD |
Dr. Suri has nothing to disclose. |
|
No disclosure on file
|
| Michael T. Mullen, MD |
Dr. Mullen has received publishing royalties from a publication relating to health care. |
| Archit Bhatt, MD |
No disclosure on file
|
| Ameer Hassan, DO |
Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare. |
| Ahmed Shatila, MD |
No disclosure on file
|
| Gereon Fink |
No disclosure on file
|
| Lonni Schultz, PhD |
Dr. Schultz has nothing to disclose. |
| Evgeny Sidorov, MD |
Dr. Sidorov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Dr. Sidorov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BioHaven . |
| Wondwossen G. Tekle, MD |
Dr. Tekle has nothing to disclose. |
| Wayne W. Feng, MD, FAAN |
Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen. |
| Daniel Miller, MD |
Dr. Miller has nothing to disclose. |
| Jennifer Simpson, MD |
Dr. Simpson has nothing to disclose. |
| Suneel K. Gupta, PhD |
No disclosure on file
|
| Michael Schroeter |
No disclosure on file
|
| Muhib Khan, MD, FAAN |
The institution of Dr. Khan has received research support from Mayo Clinic 好色先生 Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants . |
| Saqib A. Chaudhry, MD |
Dr. Chaudhry has nothing to disclose. |
| Shahram Majidi, MD |
Dr. Majidi has nothing to disclose. |
| Andrew M. Kelly, MBBS, FRACP |
No disclosure on file
|
| Carol A. Hoffman, PhD, MS, CGC |
No disclosure on file
|